ELN 2017 Classification Significantly Impacts on the Risk of Early Death in Acute Myeloid Leukemia Patients Receiving Intensive Induction Chemotherapy

被引：0
|
作者：
Froim, Naama Keren [1 ]
Heering, Gabriel [2 ]
Sharvit, Gal [2 ]
Zlotnick, Maya [3 ]
Nagler, Arnon [4 ]
Shimoni, Avichai [5 ]
Avigdor, Abraham [6 ]
Canaani, Jonathan [7 ]
机构：
[1] Sheba Med Ctr, Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel
[4] Chaim Sheba Med Ctr, Div Hematol, Tel Hashomer, Israel
[5] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel
[6] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Tel Hashomer, Israel
[7] Sheba Med Ctr, Div Hematol, Giv'atayim, Israel
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-145551
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3392
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The prognostic role of serum albumin in patients receiving induction chemotherapy for acute myeloid leukemia (AML)
    Sadrzadeh, Hossein
    Brunner, Andrew Mark
    Drapkin, Benjamin Jacob
    Babirak, Loren
    Werner, Lillian
    Ballen, Karen K.
    Amrein, Philip C.
    Attar, Eyal C.
    Chen, Yi-Bin Albert
    Spitzer, Thomas R.
    McAfee, Steven L.
    Neuberg, Donna S.
    Fathi, Amir Tahmasb
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Ball, Brian J.
    Hsu, Meier
    Devlin, Sean M.
    Arcila, Maria
    Roshal, Mikhail
    Zhang, Yanming
    Famulare, Chris A.
    Goldberg, Aaron D.
    Cai, Sheng F.
    Dunbar, Andrew
    Epstein-Peterson, Zachary
    Menghrajani, Kamal N.
    Glass, Jacob L.
    Taylor, Justin
    Viny, Aaron D.
    Giralt, Sergio S.
    Gyurkocza, Boglarka
    Shaffer, Brian C.
    Tamari, Roni
    Levine, Ross L.
    Tallman, Martin S.
    Stein, Eytan M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E171 - E175
  • [23] Use of carbapenems and glycopeptides increases risk forClostridioides difficileinfections in acute myeloid leukemia patients undergoing intensive induction chemotherapy
    Ballo, Olivier
    Kreisel, Eva-Maria
    Eladly, Fagr
    Brunnberg, Uta
    Stratmann, Jan
    Hunyady, Peter
    Hogardt, Michael
    Wichelhaus, Thomas A.
    Kempf, Volkhard A. J.
    Steffen, Bjoern
    Vehreschild, Joerg J.
    Vehreschild, Maria J. G. T.
    Finkelmeier, Fabian
    Serve, Hubert
    Brandts, Christian H.
    ANNALS OF HEMATOLOGY, 2020, 99 (11) : 2547 - 2553
  • [24] Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia
    Malfuson, Jean-Valere
    Etienne, Anne
    Turlure, Pascal
    de Revel, Thierry
    Thomas, Xavier
    Contentin, Nathalie
    Terre, Christine
    Rigaudeau, Sophie
    Bordessoule, Dominique
    Vey, Norbert
    Gardin, Claude
    Dombret, Herve
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1806 - 1813
  • [25] Predictive performance of early warning scores in acute leukemia patients receiving induction chemotherapy
    Vaughn, John L.
    Kline, David
    Denlinger, Nathan M.
    Andritsos, Leslie A.
    Exline, Matthew C.
    Walker, Alison R.
    LEUKEMIA & LYMPHOMA, 2018, 59 (06) : 1498 - 1500
  • [26] Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy
    Schuler, Esther
    Zadrozny, Natalie
    Blum, Sabine
    Schroeder, Thomas
    Strupp, Corinna
    Hildebrandt, Barbara
    Kuendgen, Andrea
    Gattermann, Norbert
    Aul, Carlo
    Kondakci, Mustafa
    Kobbe, Guido
    Haas, Rainer
    Germing, Ulrich
    ANNALS OF HEMATOLOGY, 2018, 97 (12) : 2325 - 2332
  • [27] Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy
    Esther Schuler
    Natalie Zadrozny
    Sabine Blum
    Thomas Schroeder
    Corinna Strupp
    Barbara Hildebrandt
    Andrea Kündgen
    Norbert Gattermann
    Carlo Aul
    Mustafa Kondakci
    Guido Kobbe
    Rainer Haas
    Ulrich Germing
    Annals of Hematology, 2018, 97 : 2325 - 2332
  • [28] Assessment of the Genomic Landscape of Intermediate Risk Acute Myeloid Leukemia As Defined By 2010 ELN Risk Classification
    Panina, Ekaterina
    Ruecker, Frank G.
    Bullinger, Lars
    Dolnik, Anna
    Herzig, Julia
    Blaette, Tamara J.
    Gaidzik, Verena I.
    Paschka, Peter
    Teleanu, Maria-Veronica
    Jahn, Nikolaus
    Schmalbrock, Laura K.
    Weber, Daniela
    Kubanek, Lena
    Kindler, Thomas
    Westermann, Joerg
    Lubbert, Michael
    Salih, Helmut R.
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2018, 132
  • [29] Impaired nutritional status among Russian and Norwegian patients receiving intensive chemotherapy for acute myeloid leukemia
    Iversen, P. O.
    Tangen, J. M.
    Ukrainchenko, E.
    Wisloff, F.
    Afanasyev, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 17 - 17
  • [30] Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy
    Areej El-Jawahri
    Gregory A. Abel
    Lara Traeger
    Lauren Waldman
    Netana Markovitz
    Harry VanDusen
    Amir Fathi
    David P. Steensma
    Thomas W. LeBlanc
    Nora K. Horick
    Daniel J. DeAngelo
    Martha Wadleigh
    Gabriela Hobbs
    Julia Foster
    Andrew M. Brunner
    Philip Amrein
    Richard M. Stone
    Jennifer S. Temel
    Joseph A. Greer
    Leukemia, 2019, 33 : 2393 - 2402
12345